Literature DB >> 32424522

Cross talk between Hsp72, HMGB1 and RAGE/ERK1/2 signaling in the pathogenesis of bronchial asthma in obese patients.

Nema Ali Soliman1, Muhammad Tarek Abdel Ghafar2, Reham Mohamed El Kolaley3, Yasser Mostafa Hafez4, Rehab E Abo Elgheit5, Marwa Mohamed Atef1.   

Abstract

BACKGROUND: The incidence of obesity-related asthma has shown a remarkable increase.
OBJECTIVES: We aimed to explore the role of heat shock protein 72 (Hsp72) and receptor for advanced glycation end products (RAGE) axis with its downstream signaling in the pathogenesis of obesity-related asthma.
METHODS: We enrolled a total of 55 subjects and divided them into three groups. Groups I and II included healthy, normal weight (n = 15) and obese (n = 15) subjects, respectively. Twenty-five obese asthmatics (group III) were subdivided into group IIIa (10 patients with mild to moderate asthma) and group IIIb (15 patients with severe asthma). High mobility group box 1 (HMGB1), interleukin 8 (IL-8), monocyte chemoattractant protein 1 (MCP-1), extracellular signal-regulated protein kinases 1 and 2 (ERK1/2), and urinary Hsp72 were immunoassayed. Hydrogen peroxide (H2O2) and free fatty acids (FFAs) levels were photometrically measured. RAGE mRNA expression was relatively quantified by real-time PCR.
RESULTS: We found significant elevations of serum HMGB1, IL-8, MCP1, ERK1/2, FFAs, and H2O2 levels as well as urinary Hsp72 levels in obese subjects compared to healthy control. These were more evident in patients with severe asthma (group IIIb). Multivariate regression analysis identified Hsp72 and ERK1/2 as independent predictors of bronchial asthma severity. Receiver operating characteristic (ROC) curve analysis revealed that areas under the curve (AUC) for Hsp72 and ERK1/2 were 0.991 and 0.981, respectively, which denotes a strong predictive value for identifying the severity of bronchial asthma in obese patients.
CONCLUSION: The current study highlights the role of Hsp72 and HMGB1/RAGE/ERK1/2 signaling cascade in the pathogenesis of bronchial asthma and its link to obesity, which could be reflected on monitoring, severity grading, and management of this disease.

Entities:  

Keywords:  Biomarkers; Obesity associated bronchial asthma; Respiratory function test; Severity

Mesh:

Substances:

Year:  2020        PMID: 32424522     DOI: 10.1007/s11033-020-05531-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  4 in total

Review 1.  GINA guidelines on asthma and beyond.

Authors:  J Bousquet; T J H Clark; S Hurd; N Khaltaev; C Lenfant; P O'byrne; A Sheffer
Journal:  Allergy       Date:  2007-02       Impact factor: 13.146

Review 2.  All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.

Authors:  Elizabeth A Oczypok; Timothy N Perkins; Tim D Oury
Journal:  Paediatr Respir Rev       Date:  2017-03-18       Impact factor: 2.726

3.  Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease.

Authors:  Ajay Duseja; Kiran K Thumburu; Ashim Das; R K Dhiman; Y K Chawla; S Bhadada; Anil Bhansali
Journal:  Indian J Gastroenterol       Date:  2007 Jul-Aug

4.  HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway.

Authors:  Lei Zhang; Xue Yang; Guoliang Jiang; Ying Yu; Jian Wu; Yangang Su; Aijun Sun; Yunzeng Zou; Hong Jiang; Junbo Ge
Journal:  Int J Mol Med       Date:  2019-07-16       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.